Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGAM | O43451 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | SI | P14410 | 1/20 | 0.46 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | KDM6B | O15054 | 1/20 | 0.31 |
| ▸ | KDM5C | P41229 | 1/20 | 0.31 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.31 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.31 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21294536 | 0.80 | LDHA (0.38) | ALDH1A1TDP1TSHRSMN1; SMN2EGLN1 | |
| SCHEMBL262554 | 0.80 | LDHA (0.38) | ALDH1A1TDP1TSHRSMN1; SMN2EGLN1 | |
| SCHEMBL16624283 | 0.80 | MGAM (0.46) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL3233649 | 0.80 | TSHR (0.32) | ALDH1A1TSHRSMN1; SMN2 | |
| SCHEMBL29116745 | 0.78 | MGAM (0.39) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL8838659 | 0.77 | MGAM (0.48) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL4454621 | 0.76 | TDP1 (0.39) | TDP1 | |
| SCHEMBL9465458 | 0.75 | MGAM (0.41) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL12201126 | 0.75 | MGAM (0.36) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL4455383 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140147687-A1 | BIOLOGICALLY ABSORBABLE COATING FOR IMPLANTABLE DEVICES BASED ON COPOLYMERS HAVING ESTER BONDS AND METHODS OF FABRICATING THE SAME | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2014-05-29 | — | — | US | disclosed |
| US-7595414-B2 | complex capable of being used for chemical vapor deposition of thin metal , or metal oxide films | UBE INDUSTRIES, LTD. (JP) | 2009-09-29 | — | — | US | disclosed |
| US-20080254216-A1 | Metal Complex Compound Comprising B-Diketonato Ligand | UBE INDUSTRIES, LTD. (JP) | 2008-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080254216-A1 | Metal Complex Compound Comprising B-Diketonato Ligand | CAD, APOB, DBI | MGAM 819/4885GAA 2307/4885SI 1861/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.